Biolog developed its revolutionary Phenotype MicroArray™ technology. This groundbreaking technology allows researchers to evaluate thousands of cellular phenotypes simultaneously in both microbial and mammalian cells. Development of array sets testing 2,000 phenotypes of microbial cells was completed and first introduced in September 2001. Now Phenotype MicroArray technology is being tested under license in many pharmaceutical and biotechnology companies for use in drug and enzyme development programs. Biolog continues to develop and patent unique and proprietary technologies that allow scientists to broadly characterize cellular functions using arrays of phenotypic tests.
People
Nathan Hamilton (Board Member)
Donald Barnby (Board Member)
Barry Bochner (VP R&D)
Edwin Fineman (Director of Finance)
Douglas Rife (VP Operations)
Competitors
Phalanx Biotech Group:
Our mission is to leverage the knowledge, understanding, and expertise of the IC foundry industry to… See Company Profile »
News
An inside look at the world’s newest quantum computing and nanotechnology center
May 15, 2013 9:01 pm
Inside this lab, your mobile phone doesn’t work. You don’t feel any outside noise or vibrations, even if a freight… Continue reading ⟩
How long until your doctor is wearing Google Glass?
May 13, 2013 3:00 pm
This story is part of a series exploring the themes of our upcoming health tech conference, May 20-21 in San… Continue reading ⟩
Re-Mission 2 games reimagine how to help kids survive cancer
April 28, 2013 7:00 pm
This story is part of a series exploring the themes of our upcoming health tech conference, May 20-21 in San… Continue reading ⟩